# Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns

> **NCT04152096** · PHASE4 · COMPLETED · sponsor: **Yuria-Pharm** · enrollment: 118 (actual)

## Conditions studied

- Burns
- Intoxication

## Interventions

- **DRUG:** Rheosorbilact®
- **DRUG:** Ringer lactate

## Key facts

- **NCT ID:** NCT04152096
- **Lead sponsor:** Yuria-Pharm
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-02
- **Primary completion:** 2020-09-30
- **Final completion:** 2021-05-12
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2025-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04152096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04152096, "Efficacy and Safety of Rheosorbilact® Solution for Infusion, in a Complex Therapy of Burns". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04152096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*